查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1363097

濫用藥物檢測服務的市場規模、佔有率和趨勢分析報告：按藥物類型、地區和細分市場分類的趨勢，2023-2030 年

Drug Of Abuse Testing Services Market Size, Share & Trends Analysis Report By Drug Type (Alcohol, Cannabis/Marijuana, Cocaine, Opioids, Amphetamine & Methamphetamine, LSD ), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10個工作天內

價格

濫用藥物測試服務市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計2030年全球濫用藥物檢測服務市場規模將達85.4億美元，2023年至2030年年複合成長率為3.91%。

發達的實驗室網路的存在和成癮的盛行是市場成長的主要促進因素。此外，社區中各種藥物使用的增加趨勢以及非法藥物和酒精檢測檢測的重要性預計將推動需求。因此，世界各地持續提供的測試正在推動成長。

此外，越來越多的精神疾病患者和因吸毒而住院的患者也推動了需求。例如，2023 年 1 月，SAMHSA 發布了 2021 年全國藥物使用和健康調查，其中提供了有關精神疾病和藥物使用程度的詳細資訊。研究發現，12歲以上人口中有16.5%（4,630萬人）患有物質使用障礙，2,950萬人患有酒精使用障礙，2,400萬人患有藥物使用障礙。

此外，公眾意識的提高以及青少年和成年人對成癮和非法藥物使用治療的未滿足的需求預計將推動對濫用藥物檢測服務行業的需求。例如，2020年8月，Averhealth宣布收購亞利桑那州治療評估篩檢中心的藥物檢測服務。因此，越來越多的玩家關注新興國家的成癮負擔最小化正在推動市場收益。這項要素正在推動公司針對濫用案件開發創新且有效的服務。

同樣，COVID-19大流行也對市場產生了一定影響。在大流行期間，青少年和成年人對大麻/大麻和鴉片類藥物成癮的增加對檢測服務產生了持續的需求。根據聯合國毒品犯罪防制署（UNODC）統計，2020年全球約有2.75億人使用毒品，而根據2021年世界毒品報告，超過3,600萬人患有吸毒障礙。這些要素正在增加對疫情後服務的需求。

此外，主要參與企業正在採取協議、併購、合作夥伴關係和產品發布等策略，以擴大其全球足跡和產品系列。例如，2022年12月，歐米茄實驗室在加拿大推出了尿液濫用藥物檢測服務。此外，從 2023 年 1 月開始，我們計劃提供尿液檢查來補充分子檢測。擴大毒理學測試服務將為消費者提供加拿大有限選擇的替代方案。

濫用藥物測試服務市場報告亮點

  • 大麻/大麻領域市場在 2022 年佔據市場最大的收益佔有率，由於大麻/大麻成癮的盛行、醫療篩檢和就業測試的需求，預計在預測期內將以最快的成長率成長。
  • 2022年，北美將擁有最大的市場佔有率。成熟市場參與者的存在、對各種成癮治療的需求、消費的成長以及青少年對大麻/大麻的成癮正在推動該地區的成長。
  • 領先的濫用藥物檢測服務主要企業不斷專注於產品發布和地理擴張，以維持其地位。

目錄

第1章 濫用藥物檢測服務市場：調查方法與範圍

第2章 濫用藥物檢測服務市場：執行摘要

  • 市場概述
  • 藥品類型簡介
  • 競爭形勢概覽

第3章 濫用藥物測試服務市場變數、趨勢和範圍

  • 市場區隔和範圍
  • 市場體系預測
    • 母市場預測
    • 相關/附隨市場預測
  • 市場動態
  • 市場促進因素分析
    • 藥物濫用的盛行及其治療需求的不斷成長
    • 政府配合措施監測藥物濫用
    • 嚴格的法律要求進行酒精和藥物測試
  • 市場抑制因素分析
    • 在一些國家，藥物測試被認為侵犯隱私權
  • 波特五力分析
  • PESTLE分析

第4章 濫用藥物檢測服務市場：按藥物類型估計和趨勢分析

  • 濫用藥物測試服務市場：藥物類型變異分析
  • 酒精
  • 大麻/大麻
  • 古柯鹼
  • 鴉片類藥物
  • 安非他明和甲基安非他明
  • LSD
  • 其他

第5章 濫用藥物檢測服務市場：按地區分類的業務分析

  • 區域市場簡介
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第6章 競爭形勢

  • 公司分類
  • 策略規劃
    • 新推出
    • 合夥
    • 獲得
    • 合作
  • 2022年主要企業市場佔有率分析
  • 企業熱力圖分析
  • 公司簡介
    • QUEST DIAGNOSTICS
    • ABBOTT
    • CLINICAL REFERENCE LABORATORY（CRL）, INC.
    • LABORATORY CORPORATION OF AMERICA HOLDINGS
    • CORDANT HEALTH SOLUTIONS
    • LEGACY MEDICAL SERVICES
    • DRUGSCAN
    • OMEGA LABORATORIES, INC.
    • PSYCHEMEDICS CORPORATION
    • MILLENNIUM HEALTH, LLC
    • MAYO CLINIC LABORATORIES
    • PRECISION DIAGNOSTICS
    • AMERICAN SUBSTANCE ABUSE PROFESSIONALS（ASAP）, INC.
    • UNITED STATES DRUG TESTING LABORATORIES（USDTL）, INC.
    • LGC GROUP
Product Code: GVR-2-68038-254-9

Drug Of Abuse Testing Services Market Growth & Trends:

The global drug of abuse testing services market size is expected to reach USD 8.54 billion by 2030, expanding at a CAGR of 3.91% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The presence of a developed laboratory network and the prevalence of addiction are key drivers for market growth. Furthermore, the increasing trend of different drug use in the community and the importance of testing for the detection of illicit drugs and alcohol is expected to drive the demand. Thereby, continued test offering across the globe has fueled the growth.

Additionally, rising psychiatric disorders patients and hospitalizations due to the consumption of the drugs have boosted the demand. For instance, January 2023, National Survey on Drug Use and Health Results Detailing Mental Illness & Substance Use Levels (2021) was announced by SAMHSA. The survey mentioned that 16.5% of the aged 12 or older population (or 46.3 million) people had a substance use disorder wherein 29.5 million people were classified to have alcohol use disorder & 24 million people had drug use disorder.

In addition, the growing awareness among the population and the unmet need for treatment of addiction and illicit medication use among youth and adults is projected to boost the demand for the drug of abuse testing services industry. For instance, in August 2020, Averhealth announced the acquisition of the drug testing services of the Treatment Assessment Screening Center in Arizona. Therefore, increasing the focus of players to minimize the burden of addiction in emerging countries propels the market revenue. This factor has led companies to develop innovative and effective services for abuse cases.

Likewise, the COVID-19 pandemic has moderately impacted the market. During the pandemic, a constant demand for detection services was attributable to the increased addiction to Cannabis/Marijuana and opioids among the youth and adult population. According to United Nations Office on Drugs and Crime (UNODC), in 2020, around 275 million people used drugs worldwide, while according to the 2021 World Drug Report, over 36 million population suffered from drug use disorders. This factor has led to rising requirements for services post-pandemic.

Furthermore, the key participants are engaged in strategies such as agreements, mergers & acquisitions, partnerships, and launches, among others, to expand their global footprints and product portfolio. For instance, in December 2022, Urine Drugs of Abuse testing services was launched by Omega Laboratories in Canada. Adding to that from January 2023, the laboratory will offer urine testing to complement its molecular testing. The expansion of toxicology services will offer consumers an alternative to limited options available in Canada.

Drug Of Abuse Testing Services Market Report Highlights:

  • Cannabis/Marijuana segment held the largest revenue share of the market in 2022 and is anticipated to grow at the fastest growth rate over the forecast period owing to the prevalence of cannabis/marijuana addiction, demand for medical screening, and employment testing drives the growth
  • North America held the largest share of the market in 2022. The presence of well-established market players, demand for various addiction treatments, growing consumption, and addiction to cannabis/marijuana among youth drive regional growth
  • Key players operating in the drug of abuse testing services constantly focus on product launches and geographical expansion to maintain their presence

Table of Contents

Chapter 1. Drug of Abuse Testing Services Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Drug Type Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Drug of Abuse Testing Services Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Drug Type Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Drug of Abuse Testing Services Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. High prevalence of substance abuse & growing demand for its treatment
    • 3.4.2. Increase in government initiatives to monitor substance abuse
    • 3.4.3. Stringent law mandating alcohol and drug testing
  • 3.5. Market Restraint Analysis
    • 3.5.1. Drug testing is considered a violation of privacy rights in some countries
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. Drug of Abuse Testing Services Market: Drug Type Estimates & Trend Analysis

  • 4.1. Drug of Abuse Testing Services Market: Drug Type Movement Analysis
  • 4.2. Alcohol
    • 4.2.1. Alcohol Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3. Cannabis/Marijuana
    • 4.3.1. Cannabis/Marijuana Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Cocaine
    • 4.4.1. Cocaine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Opioids
    • 4.5.1. Opioids Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Amphetamine & Methamphetamine
    • 4.6.1. Amphetamine & Methamphetamine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. LSD
    • 4.7.1. LSD Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Drug of Abuse Testing Services Market: Regional Business Analysis

  • 5.1. Regional Market Snapshot
  • 5.2. North America
    • 5.2.1. North America Drug of Abuse Testing Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.2.2. U.S.
      • 5.2.2.1. U.S. Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.2.2.2. Key Country Dynamics
      • 5.2.2.3. Regulatory Framework
      • 5.2.2.4. Reimbursement Scenario
      • 5.2.2.5. Competitive Scenario
    • 5.2.3. Canada
      • 5.2.3.1. Canada Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.2.3.2. Key Country Dynamics
      • 5.2.3.3. Regulatory Framework
      • 5.2.3.4. Reimbursement Scenario
      • 5.2.3.5. Competitive Scenario
  • 5.3. Europe
    • 5.3.1. Europe Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
    • 5.3.2. Germany
      • 5.3.2.1. Germany Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.3.2.2. Key Country Dynamics
      • 5.3.2.3. Regulatory Framework
      • 5.3.2.4. Reimbursement Scenario
      • 5.3.2.5. Competitive Scenario
    • 5.3.3. UK
      • 5.3.3.1. UK Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.3.3.2. Key Country Dynamics
      • 5.3.3.3. Regulatory Framework
      • 5.3.3.4. Reimbursement Scenario
      • 5.3.3.5. Competitive Scenario
    • 5.3.4. France
      • 5.3.4.1. France Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.3.4.2. Key Country Dynamics
      • 5.3.4.3. Regulatory Framework
      • 5.3.4.4. Reimbursement Scenario
      • 5.3.4.5. Competitive Scenario
    • 5.3.5. Spain
      • 5.3.5.1. Spain Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.3.5.2. Key Country Dynamics
      • 5.3.5.3. Regulatory Framework
      • 5.3.5.4. Reimbursement Scenario
      • 5.3.5.5. Competitive Scenario
    • 5.3.6. Italy
      • 5.3.6.1. Italy Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.3.6.2. Key Country Dynamics
      • 5.3.6.3. Regulatory Framework
      • 5.3.6.4. Reimbursement Scenario
      • 5.3.6.5. Competitive Scenario
    • 5.3.7. Denmark
      • 5.3.7.1. Denmark Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.3.7.2. Key Country Dynamics
      • 5.3.7.3. Regulatory Framework
      • 5.3.7.4. Reimbursement Scenario
      • 5.3.7.5. Competitive Scenario
    • 5.3.8. Norway
      • 5.3.8.1. Norway Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.3.8.2. Key Country Dynamics
      • 5.3.8.3. Regulatory Framework
      • 5.3.8.4. Reimbursement Scenario
      • 5.3.8.5. Competitive Scenario
    • 5.3.9. Sweden
      • 5.3.9.1. Sweden Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.3.9.2. Key Country Dynamics
      • 5.3.9.3. Regulatory Framework
      • 5.3.9.4. Reimbursement Scenario
      • 5.3.9.5. Competitive Scenario
  • 5.4. Asia Pacific
    • 5.4.1. Asia-Pacific Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
    • 5.4.2. Japan
      • 5.4.2.1. Japan Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.4.2.2. Key Country Dynamics
      • 5.4.2.3. Regulatory Framework
      • 5.4.2.4. Reimbursement Scenario
      • 5.4.2.5. Competitive Scenario
    • 5.4.3. China
      • 5.4.3.1. China Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.4.3.2. Key Country Dynamics
      • 5.4.3.3. Regulatory Framework
      • 5.4.3.4. Reimbursement Scenario
      • 5.4.3.5. Competitive Scenario
    • 5.4.4. India
      • 5.4.4.1. India Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.4.4.2. Key Country Dynamics
      • 5.4.4.3. Regulatory Framework
      • 5.4.4.4. Reimbursement Scenario
      • 5.4.4.5. Competitive Scenario
    • 5.4.5. Australia
      • 5.4.5.1. Australia Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.4.5.2. Key Country Dynamics
      • 5.4.5.3. Regulatory Framework
      • 5.4.5.4. Reimbursement Scenario
      • 5.4.5.5. Competitive Scenario
    • 5.4.6. South Korea
      • 5.4.6.1. South Korea Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.4.6.2. Key Country Dynamics
      • 5.4.6.3. Regulatory Framework
      • 5.4.6.4. Reimbursement Scenario
      • 5.4.6.5. Competitive Scenario
    • 5.4.7. Thailand
      • 5.4.7.1. Thailand Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.4.7.2. Key Country Dynamics
      • 5.4.7.3. Regulatory Framework
      • 5.4.7.4. Reimbursement Scenario
      • 5.4.7.5. Competitive Scenario
  • 5.5. Latin America
    • 5.5.1. Latin America Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
    • 5.5.2. Brazil
      • 5.5.2.1. Brazil Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.5.2.2. Key Country Dynamics
      • 5.5.2.3. Regulatory Framework
      • 5.5.2.4. Reimbursement Scenario
      • 5.5.2.5. Competitive Scenario
    • 5.5.3. Mexico
      • 5.5.3.1. Mexico Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.5.3.2. Key Country Dynamics
      • 5.5.3.3. Regulatory Framework
      • 5.5.3.4. Reimbursement Scenario
      • 5.5.3.5. Competitive Scenario
    • 5.5.4. Argentina
      • 5.5.4.1. Argentina Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.5.4.2. Key Country Dynamics
      • 5.5.4.3. Regulatory Framework
      • 5.5.4.4. Reimbursement Scenario
      • 5.5.4.5. Competitive Scenario
  • 5.6. MEA
    • 5.6.1. MEA Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
    • 5.6.2. South Africa
      • 5.6.2.1. South Africa Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.6.2.2. Key Country Dynamics
      • 5.6.2.3. Regulatory Framework
      • 5.6.2.4. Reimbursement Scenario
      • 5.6.2.5. Competitive Scenario
    • 5.6.3. Saudi Arabia
      • 5.6.3.1. Saudi Arabia Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.6.3.2. Key Country Dynamics
      • 5.6.3.3. Regulatory Framework
      • 5.6.3.4. Reimbursement Scenario
      • 5.6.3.5. Competitive Scenario
    • 5.6.4. UAE
      • 5.6.4.1. UAE Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.6.4.2. Key Country Dynamics
      • 5.6.4.3. Regulatory Framework
      • 5.6.4.4. Reimbursement Scenario
      • 5.6.4.5. Competitive Scenario
    • 5.6.5. Kuwait
      • 5.6.5.1. Kuwait Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.6.5.2. Key Country Dynamics
      • 5.6.5.3. Regulatory Framework
      • 5.6.5.4. Reimbursement Scenario
      • 5.6.5.5. Competitive Scenario

Chapter 6. Competitive Landscape

  • 6.1. Company Categorization
  • 6.2. Strategy Mapping
    • 6.2.1. New Launch
    • 6.2.2. Partnerships
    • 6.2.3. Acquisition
    • 6.2.4. Collaboration
  • 6.3. Key Company Market Share Analysis, 2022
  • 6.4. Company Heat Map Analysis
  • 6.5. Company Profiles
    • 6.5.1. QUEST DIAGNOSTICS
      • 6.5.1.1. Company Overview
      • 6.5.1.2. Financial Performance
      • 6.5.1.3. Product Benchmarking
      • 6.5.1.4. Strategic Initiatives
    • 6.5.2. ABBOTT
      • 6.5.2.1. Company Overview
      • 6.5.2.2. Financial Performance
      • 6.5.2.3. Product Benchmarking
      • 6.5.2.4. Strategic Initiatives
    • 6.5.3. CLINICAL REFERENCE LABORATORY (CRL), INC.
      • 6.5.3.1. Company Overview
      • 6.5.3.2. Financial Performance
      • 6.5.3.3. Product Benchmarking
      • 6.5.3.4. Strategic Initiatives
    • 6.5.4. LABORATORY CORPORATION OF AMERICA HOLDINGS
      • 6.5.4.1. Company Overview
      • 6.5.4.2. Financial Performance
      • 6.5.4.3. Product Benchmarking
      • 6.5.4.4. Strategic Initiatives
    • 6.5.5. CORDANT HEALTH SOLUTIONS
      • 6.5.5.1. Company Overview
      • 6.5.5.2. Financial Performance
      • 6.5.5.3. Product Benchmarking
      • 6.5.5.4. Strategic Initiatives
    • 6.5.6. LEGACY MEDICAL SERVICES
      • 6.5.6.1. Company Overview
      • 6.5.6.2. Financial Performance
      • 6.5.6.3. Product Benchmarking
      • 6.5.6.4. Strategic Initiatives
    • 6.5.7. DRUGSCAN
      • 6.5.7.1. Company Overview
      • 6.5.7.2. Financial Performance
      • 6.5.7.3. Product Benchmarking
      • 6.5.7.4. Strategic Initiatives
    • 6.5.8. OMEGA LABORATORIES, INC.
      • 6.5.8.1. Company Overview
      • 6.5.8.2. Financial Performance
      • 6.5.8.3. Product Benchmarking
      • 6.5.8.4. Strategic Initiatives
    • 6.5.9. PSYCHEMEDICS CORPORATION
      • 6.5.9.1. Company Overview
      • 6.5.9.2. Financial Performance
      • 6.5.9.3. Product Benchmarking
      • 6.5.9.4. Strategic Initiatives
    • 6.5.10. MILLENNIUM HEALTH, LLC
      • 6.5.10.1. Company Overview
      • 6.5.10.2. Financial Performance
      • 6.5.10.3. Product Benchmarking
      • 6.5.10.4. Strategic Initiatives
    • 6.5.11. MAYO CLINIC LABORATORIES
      • 6.5.11.1. Company Overview
      • 6.5.11.2. Financial Performance
      • 6.5.11.3. Product Benchmarking
      • 6.5.11.4. Strategic Initiatives
    • 6.5.12. PRECISION DIAGNOSTICS
      • 6.5.12.1. Company Overview
      • 6.5.12.2. Financial Performance
      • 6.5.12.3. Product Benchmarking
      • 6.5.12.4. Strategic Initiatives
    • 6.5.13. AMERICAN SUBSTANCE ABUSE PROFESSIONALS (ASAP), INC.
      • 6.5.13.1. Company Overview
      • 6.5.13.2. Financial Performance
      • 6.5.13.3. Product Benchmarking
      • 6.5.13.4. Strategic Initiatives
    • 6.5.14. UNITED STATES DRUG TESTING LABORATORIES (USDTL), INC.
      • 6.5.14.1. Company Overview
      • 6.5.14.2. Financial Performance
      • 6.5.14.3. Product Benchmarking
      • 6.5.14.4. Strategic Initiatives
    • 6.5.15. LGC GROUP
      • 6.5.15.1. Company Overview
      • 6.5.15.2. Financial Performance
      • 6.5.15.3. Product Benchmarking
      • 6.5.15.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global Drug of Abuse Testing Services Market, By Region, 2018 - 2030 (USD Million)
  • Table 4 North America Drug of Abuse Testing Services Market, By Country, 2018 - 2030 (USD Million)
  • Table 5 North America Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 6 U.S. Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 7 Canada Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 8 Europe Drug of Abuse Testing Services Market, By Country, 2018 - 2030 (USD Million)
  • Table 9 Europe Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 10 Germany Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 11 UK Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 12 France Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 13 Spain Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 14 Italy Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 15 Denmark Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 16 Norway Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 17 Sweden Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 18 Asia Pacific Drug of Abuse Testing Services Market, By Country, 2018 - 2030 (USD Million)
  • Table 19 Asia Pacific Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 20 Japan Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 21 China Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 22 India Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 23 Australia Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 24 South Korea Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 25 Thailand Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 26 Latin America Drug of Abuse Testing Services Market, By Country, 2018 - 2030 (USD Million)
  • Table 27 Latin America Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 28 Brazil Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 29 Mexico Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 30 Argentina Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 31 Middle East & Africa Drug of Abuse Testing Services Market, By Country, 2018 - 2030 (USD Million)
  • Table 32 Middle East & Africa Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 33 Saudi Arabia Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 34 South Africa Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 35 UAE Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 36 Kuwait Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market summary
  • Fig. 4 Market segmentation & scope
  • Fig. 5 Market size and growth prospects
  • Fig. 6 Global drug of abuse testing services market - Key market driver analysis
  • Fig. 7 Global drug of abuse testing services market - Key market restraint analysis
  • Fig. 8 Penetration & growth prospect mapping
  • Fig. 9 Global drug of abuse testing services market - Porter's analysis
  • Fig. 10 Global drug of abuse testing services market - PESTEL analysis
  • Fig. 11 Global drug of abuse testing services market drug type outlook key takeaways
  • Fig. 12 Global drug of abuse testing services market: Drug type movement analysis
  • Fig. 13 Alcohol market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 14 Cannabis/Marijuana market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Cocaine market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Opioids market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Amphetamine & Methamphetamine market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 LSD market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Regional marketplace: Key takeaways
  • Fig. 21 Global drug of abuse testing services market: Regional movement analysis
  • Fig. 22 North America drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 23 U.S. drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 24 Canada drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 25 Europe drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 26 Germany drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 27 UK drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 28 France drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 29 Spain drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 30 Italy drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 31 Denmark drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 32 Norway drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 33 Sweden drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 34 Asia Pacific drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 35 Japan drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 36 China drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 37 India drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 38 Australia drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 39 South Korea drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 40 Thailand drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 41 Latin America drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 42 Brazil drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 43 Mexico drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 44 Argentina drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 45 MEA drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 46 South Africa drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 47 Saudi Arabia drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 48 UAE drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 49 Kuwait drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 50 Strategy framework